Adjunct Associate Lecturer

Dr Tamara Milder

Medicine & Health
School of Clinical Medicine
  • Journal articles | 2023
    Milder TY; Greenfield JR; Milder DA, 2023, 'Peri-procedural ketoacidosis risk with sodium-glucose cotransporter 2 inhibitor use in people without diabetes', Anaesthesia,
    Journal articles | 2023
    Milder TY; Stocker SL; Baysari MT; Day RO; Greenfield JR, 2023, '‘We are somehow fixated on this being a diabetes drug’: a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation', Internal Medicine Journal,
    Journal articles | 2022
    Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'Prescribing of SGLT2 Inhibitors in Clinical Practice: A Qualitative Study of Cardiologists', Heart, Lung and Circulation, 31, pp. S96 - S97,
    Journal articles | 2022
    Tiwary M; Milder TY; Stocker SL; Day RO; Greenfield JR, 2022, 'Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction', Internal Medicine Journal, 52, pp. 1666 - 1676,
    Journal articles | 2021
    Milder T; Stocker S; Baysari M; Day RO; Greenfield J, 2021, 'Prescribing of SGLT2 Inhibitors in Primary Care: A Qualitative Study of Primary Care Physicians and Endocrinologists', DIABETES, 70,
    Journal articles | 2021
    Milder TY; Stocker SL; Baysari M; Day RO; Greenfield JR, 2021, 'Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists', Diabetes Research and Clinical Practice, 180, pp. 109036,
    Journal articles | 2020
    Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, 50, pp. 645 - 646,
    Journal articles | 2020
    Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, 43, pp. 1211 - 1221,
    Journal articles | 2019
    Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR, 2019, 'Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease', European Journal of Clinical Pharmacology, 75, pp. 1481 - 1490,
    Journal articles | 2019
    Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8,
    Journal articles | 2019
    2019, 'Book review: Therapeutic Guidelines: Diabetes. Version 1', Australian Prescriber, 42, pp. 205 - 205,
    Journal articles | 2018
    Milder DA; Milder TY; Kam PCA, 2018, 'Sodium-glucose co-transporter type-2 inhibitors: pharmacology and peri-operative considerations', Anaesthesia, 73, pp. 1008 - 1018,
    Journal articles | 2011
    Milder T; Lipworth WL; Williams KM; Ritchie JE; Day RO, 2011, '"It looks after me": how older patients make decisions about analgesics for osteoarthritis.', Arthritis Care and Research, 63, pp. 1280 - 1286,
  • Conference Abstracts | 2017
    Milder TY; Greenfield J; Matthews G; Center J, 2017, 'Hypophosphataemic osteomalacia induced by tenofovir disoproxil fumarate', in CLINICAL ENDOCRINOLOGY, WILEY, AUSTRALIA, Perth, Vol. 89, pp. 70 - 70, presented at Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), AUSTRALIA, Perth, 27 August 2017 - 30 August 2017,